Related Experiment Video
Updated: Jul 14, 2026
10:41
Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Geste antagonistes in idiopathic lower cranial dystonia
Steven E Lo1, Michael Gelb, Steven J Frucht
1The Neurological Institute, Columbia University Medical Center, New York, New York, USA.
Summary
Sensory tricks, known as geste antagonistes, can temporarily alleviate symptoms in lower cranial dystonia. Researchers developed oral appliances mimicking these tricks, with some patients finding sustained benefit.
Area of Science:
- Neurology
- Movement Disorders
Background:
- Geste antagoniste (sensory tricks) are recognized in focal dystonia of the neck, hand, and face.
- These tricks provide temporary relief from dystonic movements, which ceases upon discontinuation.
Purpose of the Study:
- To investigate the phenomenological characteristics of geste antagoniste maneuvers in idiopathic lower cranial dystonia.
- To explore the potential of mimicking sensory tricks with oral appliances for sustained symptom management.
Main Methods:
- Prospective evaluation of 19 patients with idiopathic lower cranial dystonia over 6 years.
- Phenomenological assessment of geste antagoniste maneuvers.
- Manufacturing and testing of oral appliances to mimic effective sensory tricks in 8 patients.
Main Results:
- The study included 19 patients (10 men) with a mean age of onset of 49.8 years.
- The jaw was the most commonly affected area (10 patients), with dystonia often being task-specific.
- Three out of 8 patients who received custom oral appliances continued to use them, indicating potential long-term benefit.
Conclusions:
- Geste antagoniste maneuvers offer temporary relief in lower cranial dystonia.
- Oral appliances mimicking sensory tricks can provide a viable, long-term management strategy for some patients.
- Further research into sensory trick-based interventions for dystonia is warranted.
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:12Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...